Home example 2 - Pharmamarketeer

technologie

EU komt met regelgeving voor deepfakes

De Europese Commissie is van plan om hoge boetes te gaan opleggen aan technologiebedrijven die geen actie ondernemen tegen deepfakes op hun platforms. Volgens Reuters worden de regels donderdag gepubliceerd als...

Emerce

5 x gelezen

marketing

How Outsourcing Content Production Can Save Your Marketing Budget

How Outsourcing Content Production Can Save Your Marketing Budget History will remember the 2010s for its significant trends – those that remain popular (the rise of the Marvel and DC universes, hipster fashion, social...

Content Marketing Institute

5 x gelezen

farma-industrie

Chinese heparin maker banned by EMA over contamination risks

World regulators are cautious about crude heparin after China-made APIs were responsible for dozens of deaths in the U.S. more than a decade ago. Now, European regulators are banning heparin from a Chinese facility...

FiercePharma

5 x gelezen

overig

Prijzen weesgeneesmiddelen blijven hoog wegens gebrek aan concurrentie

Prijzen weesgeneesmiddelen blijven hoog wegens gebrek aan concurrentie De kosten van geneesmiddelen voor zeldzame aandoeningen dalen nauwelijks na de exclusiviteitsperiode van tien jaar. Dit komt vooral doordat er te...

Arts en Apotheker

5 x gelezen

wet- en regelgeving

US FDA approves Novartis’ Beovu for wet age─related macular degeneration treatment

Novartis, a leading global medicines company, announced that the US Food and Drug Administration (FDA) approved Beovu (brolucizumab) injection, also known as RTH258 for the treatment of wet age─related macular...

Pharma Biz

5 x gelezen

marketing

Doelgerichte content: bepaal de juiste metrics [infographic]

Doelgerichte content Content maken omdat je content wil maken, dat is een slecht idee. Want als je geen specifieke doelen stelt voor je content, kun je ook niet meten of je content het goed doet. Veel pageviews hoeft...

Frankwatching.nl

5 x gelezen

marketing

Future of TV Briefing: Short-form video rev-share options mount but have yet to amount to much

Future of TV Briefing: Short-form video This week’s Future of TV Briefing assesses the revenue-sharing options for short-form vertical video creators. Short-changedYouTube’s TV viewership, the WGA strike’s upfront...

digiday.com

5 x gelezen

onderzoek

AstraZeneca presents advances in improving treatment options for ovarian, lung cancer patients at ESMO 2018 Congress

AstraZeneca and MedImmune, its global biologics research and development arm, will present 54 abstracts, including eight oral presentations and three late breakers, to the European Society of Medical Oncology (ESMO...

Pharma Biz

5 x gelezen

wet- en regelgeving

FDA gifts Alexion quick OK for Soliris follow-up Ultomiris

Alexion was expecting a decision on its Soliris successor by February, but thanks to a quick review from U.S. regulators, it’s made its way onto 2018’s list of new drug approvals.

FiercePharma

5 x gelezen

farma-industrie

MS Pharma ink deal for acquisition of Genepharm

Jordanian firm MS Pharma has entered into an agreement to acquire 100% of the outstanding shares of Greek company Genepharm. The deal is expected to close by the end of April. Genepharm, a company which develops...

InPharm.com

5 x gelezen

Latest articles

EU komt met regelgeving voor deepfakes

How Outsourcing Content Production Can Save Your Marketing Budget

Chinese heparin maker banned by EMA over contamination risks

Prijzen weesgeneesmiddelen blijven hoog wegens gebrek aan concurrentie

US FDA approves Novartis’ Beovu for wet age─related macular degeneration treatment

Doelgerichte content: bepaal de juiste metrics [infographic]

Future of TV Briefing: Short-form video rev-share options mount but have yet to amount to much

AstraZeneca presents advances in improving treatment options for ovarian, lung cancer patients at ESMO 2018 Congress

FDA gifts Alexion quick OK for Soliris follow-up Ultomiris

MS Pharma ink deal for acquisition of Genepharm

Wekelijkse highlights per e-mail

Algemene informatie